This is a preview of subscription content, log in via an institution to check access.
References
Inman WHW. An introduction to prescription event monitoring. In: Mann RD, editor. Adverse drug reactions: the scale and nature of the problem and the way forward. Carnforth:Parthenon Publishing, 1987: 177–99
Novitch M. International adverse reaction surveillance. Drug Inf J 1985; 19: 209–12
Bateman DN, Chaplin S. Adverse reactions. BMJ 1988; 296: 761–4
Buckley G. Monitoring the safety of drugs. MIMS Magazine 1988; 15 March: 35–7
Griffin JP. Adverse drug reaction monitoring in 16 countries and the contribution of the pharmaceutical industry to drug safety. In: Mann RD, editor. Adverse drug reactions: the scale and nature of the problem and the way forward. Carnforth: Parthenon Publishing, 1987: 75–105
Griffin JP, Weber JCP. Voluntary systems of adverse drug reaction reporting Part II. Adv Drug React Ac Pois Rev 1986; 1: 23–55
Mann RD. The yellow card data: The nature and scale of the adverse drug reactions problem. In: Mann RD editor. Adverse drug reactions: the scale and nature of the problem and the way forward. Carnforth: Parthenon Publishing, 1987: 5–66
Hardman C, Lloyd B. Adverse drug reaction monitoring by ward pharmacists. J Clin Hosp Pharm 1982; 7: 71–3
Spencer MGL. Post Marketing Surveillance. Pharm J 1985; 235: 372–5
Irvin LE, Grimmer SFM, Smith JC. Adverse drug reaction reporting. Br J Pharm Prac 1987; 9: 316–21
Edwards C, Smith JM, Bateman DN, et al. Adverse drug reaction monitoring in hospitals: a study of a pharmacy (green card) monitoring scheme in the Northern Region. Pharm J 1989; 243: R48
Lee A, Bateman DN, Edwards C, et al. Adverse drug reaction reporting by hospital pharmacists. Pharm J 1993; 251: R19
Wolfson DJ, Booth, TG, Roberts PI. The community pharmacist and adverse drug reaction monitoring: (2) An examination of the potential role in the United Kingdom. Pharm J 1993; 251: 21–4
Whittlesea C, Walker R, Houghton J, et al. Development of an adverse drug reaction reporting scheme for community pharmacists. Pharm J 1993; 251: R20
Taras-Zasowski KM, Einarson TR. Review of Canadian pharmacist involvement in adverse drug reaction reporting. Can J Hosp Pharm 1989; 42: 105–8
Fincham JE. Adverse drug reaction reporting and pharmacists. J Clin Pharm Ther 1989; 14: 79–81
Wu L, Strozyk WR, Underwood DA, et al. Comprehensive multidisciplinary adverse drug reaction reporting system in a community hospital. 49th Annual ASHP Meeting; 1992 May 31–June 4; Washington DC. Bethesda (MD): ASHP, 1992: P–6D
Fincham JE. Monitoring and managing adverse drug reactions. Am Pharm 1992; 32: 74–82
Fincham JE, Szeinbach SL. Mississippi Adverse Drug Reaction Reporting Program; beginnings to the present. Clin Res Pract Drug Regul Aff 1990; 8: 45–63
Prosser TR, Kamysz PL. Multidisciplinary adverse drug reaction surveillance program. Am J Hosp Pharm 1990; 47: 1334–9
Steeqhs MH, de-Koning FH. Therapeutic measures taken by an adverse drug reactions surveillance program in every day clinical practice. 24th Annual ASHPMidyear Clinical Meeting; 1989 December 3–7; Atlanta. Bethesda (MD): ASHP, 1989: CP–4
Haaijer-Ruskamp FM, de Jong-van den Berg LT. Drug utilization studies and drug monitoring in the Netherlands. Ann Ist Super Sanita 1991; 27: 217–23
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roberts, P.I., Wolfson, D.J. & Booth, T.G. The Role Of Pharmacists in Adverse Drug Reaction Reporting. Drug-Safety 11, 7–11 (1994). https://doi.org/10.2165/00002018-199411010-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199411010-00002